ARQT

ARQT Net Income Growth

130.58%TTM

Period ending:

ARQT TTM Net Income YoY %%
ARQT TTM Net Income YoY %173.37%-268.80%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ARQT net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Arcutis Biotherapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
130.5765%
98.1683%
88.4739%
77.3319%
53.0743%
40.3386%
46.5045%
26.9061%
39.8519%
33.4839%
15.9511%
13.9182%
-27.0809%
-39.3086%
-50.9324%
-83.7987%
-73.0079%
-63.2753%
-52.0925%
-48.0591%
-66.1302%
-126.8425%
-223.0736%
-226.007%
-220.5534%
-176.3644%
-118.1157%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All ARQT financial metrics · ARQT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.